Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma
oleh: Christian Winther Eskelund, Alexandra Albertsson-Lindblad, Arne Kolstad, Anna Laurell, Riikka Räty, Lone Bredo Pedersen, Christian Hartmann Geisler, Mats Jerkeman, Kirsten Grønbæk
| Format: | Article |
|---|---|
| Diterbitkan: | Ferrata Storti Foundation 2018-11-01 |
Deskripsi
No description available for this item.